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Abstract
Background—Acute ethanol administration increases plasma and brain levels of progesterone
and deoxycorticosterone-derived neuroactive steroids (3α,5α)-3-hydroxypregnan-20-one (3α,5α-
THP) and (3α,5α)-3,21-dihydroxypregnan-20-one (3α,5α-THDOC) in rats. However, little is
known about ethanol effects on GABAergic neuroactive steroids in mice, non-human primates or
humans. We investigated the effects of ethanol on plasma levels of 3α,5α- and 3α,5β-reduced
GABAergic neuroactive steroids derived from progesterone, deoxycorticosterone,
dehydroepiandrosterone and testosterone using gas chromatography-mass spectrometry.
Methods—Serum levels of GABAergic neuroactive steroids and pregnenolone were measured in
male rats, C57BL/6J and DBA/2J mice, cynomolgus monkeys and humans following ethanol
administration. Rats and mice were injected with ethanol (0.8 – 2.0 g/kg), cynomolgus monkeys
received ethanol (1.5 g/kg) intragastrically and healthy men consumed a beverage containing 0.8
g/kg ethanol. Steroids were measured after 60 minutes in all species and also after 120 minutes in
monkeys and humans.
Results—Ethanol administration to rats increased levels of 3α,5α-THP, 3α,5α-THDOC and
pregnenolone at the doses of 1.5 g/kg (+228, +134 and +860%, respectively, p<0.001) and 2.0 g/
kg (+399, +174 and +1125%, respectively, p<0.001), but not at the dose of 0.8 g/kg. Ethanol did
not alter levels of the other neuroactive steroids. In contrast, C57BL/6J mice exhibited a 27%
decrease in serum 3α,5α-THP levels (p<0.01), while DBA/2J mice showed no significant effect of
ethanol, although both mouse strains exhibited substantial increases in precursor steroids. Ethanol
did not alter any of the neuroactive steroids in cynomolgus monkeys at doses comparable to those
studied in rats. Finally, no effect of ethanol (0.8 g/kg) was observed in men.
Conclusions—These studies show clear species differences among rats, mice and cynomolgus
monkeys in the effects of ethanol administration on circulating neuroactive steroids. Rats are
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unique in their pronounced elevation of GABAergic neuroactive steroids, while this effect was not
observed in mice or cynomolgus monkeys at comparable ethanol doses.
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Introduction
Neuroactive steroids are endogenous neuromodulators, synthesized de novo in the brain as
well as in the adrenals and gonads. They have potent effects on neurotransmission mediated
by γ-aminobutyric acid type A (GABAA) receptors (Paul and Purdy, 1992) on which they
act through specific binding sites on the α subunits (Hosie et al., 2006). The 3α,5α- and 3α,
5β-reduced metabolites of progesterone, deoxycorticosterone, dehydroepiandrosterone
(DHEA) and testosterone (Frye et al., 1996; Kaminski et al., 2005; Majewska et al., 1986)
induce GABAergic actions that result in anxiolytic, anticonvulsant, sedative/hypnotic and
cognitive effects (Biggio and Purdy, 2001; Morrow, 2007).
GABAergic neuroactive steroids play a crucial role in physiological states like stress (Purdy
et al., 1991), pregnancy (Concas et al., 1998), ovarian cycling (Genazzani et al., 1998;
Maguire et al., 2005), puberty (Grobin and Morrow, 2001; Shen et al., 2007) and aging
(Schumacher et al., 2003). GABAergic neuroactive steroid levels are altered in several mood
and emotional disorders, including anxiety, depression, premenstrual dysphoric disorder,
schizophrenia, epilepsy and drug addiction (Girdler et al., 2001; Kaminski et al., 2005; Marx
et al., 2006b; Morrow et al., 2006; Uzunova et al., 1998). Furthermore, neuroactive steroids
possess neuroprotective and neurotrophic effects (Djebaili et al., 2005; Griffin et al., 2004;
Wang et al., 2005) and their levels are altered in neurodegenerative diseases (Marx et al.,
2006d). The neuroactive steroid 3α,5α-THP is increased in rat plasma and brain by
administration of various psychoactive drugs, including ethanol (Morrow et al., 1998),
caffeine (Concas et al., 2000), nicotine (Porcu et al., 2003), tetrahydrocannabinol (Grobin et
al., 2005), morphine (Concas et al., 2006; Grobin et al., 2005), antidepressants (Pisu and
Serra, 2004; Uzunov et al., 1996; Uzunova et al., 1998) and certain antipsychotics like
clozapine and olanzapine (Barbaccia et al., 2001; Marx et al., 2000; Marx et al., 2006a;
Marx et al., 2003).
Specifically, systemic administration of moderate doses of ethanol (1–2.5 g/kg) increases
brain and plasma levels of (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP), (3α,5α)-3,21-
dihydroxypregnan-20-one (3α,5α-THDOC) and their precursors in rodents (Barbaccia et al.,
1999; Finn et al., 2004c; Gabriel et al., 2004; Khisti et al., 2005; Korneyev et al., 1993;
Morrow et al., 1999; Morrow et al., 1998; O'Dell et al., 2004; Serra et al., 2003; VanDoren
et al., 2000). The ethanol-induced increase in neuroactive steroids is mediated by the
hypothalamic-pituitary-adrenal (HPA) axis, since it is no longer observed following
adrenalectomy (Khisti et al., 2003; O'Dell et al., 2004; Porcu et al., 2004) or
hypophysectomy (Boyd et al., 2009). However, ethanol can increase neuroactive steroids in
hippocampal slices from both intact (Sanna et al., 2004) and adrenalectomized/
gonadectomized rats (Follesa et al., 2006).
Ethanol-induced elevations in neuroactive steroids reach physiologically relevant
concentrations that are capable of enhancing GABAergic transmission. A large body of
evidence from multiple laboratories suggests that ethanol-induced elevations of GABAergic
neuroactive steroids contribute to several behavioral effects of ethanol in rodents.
Neuroactive steroids have been shown to modulate ethanol’s anticonvulsant effects
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(VanDoren et al., 2000), sedation (Khisti et al., 2003), impairment of spatial memory
(Matthews et al., 2002; Morrow et al., 2001), anxiolytic-like (Hirani et al., 2005),
antidepressant-like (Hirani et al., 2002) and proaggressive actions (Fish et al., 2001). These
behavioral responses are modulated by pretreatment with finasteride and/or by prior
adrenalectomy. The hypnotic effect of ethanol is partially blocked by adrenalectomy.
Importantly, administration of 5α-dihydroprogesterone, the immediate precursor of 3α,5α-
THP, to adrenalectomized rats restores effects of ethanol, implying that brain synthesis of
neuroactive steroids also contributes to the effects of ethanol in vivo (Khisti et al., 2003).
However, neuroactive steroids do not appear to influence the motor incoordinating effects of
ethanol, since neither finasteride administration nor adrenalectomy diminish these actions
(Khisti et al., 2004). Taken together, these studies suggest that elevations in neuroactive
steroids influence many of the GABAergic effects of ethanol in vivo and contribute to
sensitivity to behavioral effects of ethanol.
Studies in mice have mainly focused on two inbred strains, C57BL/6J and DBA/2J mice.
While orally consumed ethanol increases brain 3α,5α-THP concentrations in male C57BL/6J
mice (Finn et al., 2004c), injection of 2 g/kg ethanol increases brain 3α,5α-THP levels in
DBA/2J male mice (Gabriel et al., 2004) but not C57BL/6J male mice (Finn et al., 2004c).
However, serum levels of neuroactive steroids have not been reported in these studies.
Indeed 3α,5α-THP modulates ethanol intake (Ford et al., 2007; Ford et al., 2005) and
reinstates ethanol seeking behavior in C57BL/6J mice (Finn et al., 2008). Furthermore, the
GABAergic neuroactive steroids are thought to modulate ethanol withdrawal severity across
mouse strains (Finn et al., 2004b; Gililland and Finn, 2007).
Only few studies are available on the effects of acute ethanol on GABAergic neuroactive
steroids in other species such as non-human primates or humans. The effects of ethanol on
GABAergic neuroactive steroids in non-human primates have never been reported to the
best of our knowledge. However, acute ethanol administration did not alter serum levels of
the steroids pregnenolone and deoxycorticosterone in cynomolgus monkeys (Porcu et al.,
2006a; Porcu et al., 2006b). In humans, results are controversial. Male and female
adolescents seen in the emergency room for alcohol intoxication had elevated 3α,5α-THP
plasma levels (Torres and Ortega, 2003; Torres and Ortega, 2004). In contrast, laboratory
administration of low or moderate doses of ethanol had no effect on plasma 3α,5α-THP
levels (Holdstock et al., 2006) or decreased 3α,5α-THP levels (Nyberg et al., 2005; Pierucci-
Lagha et al., 2006). However, some of the subjective effects of ethanol are diminished by
prior administration of the neuroactive steroid inhibitor finasteride (Pierucci-Lagha et al.,
2005), suggesting a role for neuroactive steroids in mediating ethanol sensitivity in humans.
Here we describe the effects of acute ethanol administration to male Sprague-Dawley rats,
male C57BL/6J and DBA/2J mice, male cynomolgus monkeys and healthy men on serum
levels of eight GABAergic neuroactive steroids. 3α,5α-THP, (3α,5β)-3-hydroxypregnan-20-
one (3α,5β-THP), 3α,5α-THDOC, (3α,5β)-3,21-dihydroxypregnan-20-one (3α,5β-THDOC),
(3α,5α)-3-hydroxyandrostan-17-one (3α,5α-androsterone), (3α,5β)-3-hydroxyandrostan-17-
one (3α,5β-androsterone), (3α,5α,17β)-androstane-3,17-diol (3α,5α-androstandiol), (3α,5β,
17β)-androstane-3,17-diol (3α,5β-androstandiol) and their precursor pregnenolone were
measured by a gas chromatography-mass spectrometry (GC-MS) assay.
Materials and Methods
Animals: rats and mice
Male Sprague-Dawley rats (200–250 g) were purchased from Harlan (Indianapolis, IN,
USA). After arrival at the animal facility, rats were allowed to acclimate for one week. They
were housed four per cage under 12h light, 12h dark cycle (light on from 0700 to 1900 h)
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and at a constant temperature of 22 ± 2°C and relative humidity of 65%. They had free
access to water and standard laboratory food at all times. Rats were habituated to handling
and intraperitoneal (i.p.) injection every day for five days before the experiment.
Male C57BL/6J and DBA/2J mice (8 weeks old) were purchased from The Jackson
Laboratories (Bar Harbor, ME, USA). After arrival at the animal facility, mice were allowed
to acclimate for one week. They were housed six per cage under 12h light, 12h dark cycle
(light on from 0700 to 1900 h) and at a constant temperature of 22 ± 2°C and relative
humidity of 65%. They had free access to water and standard laboratory food at all times.
Ethanol (0.8, 1.5 or 2.0 g/kg, 20% v/v in saline) or saline were administered to rats or mice
by intraperitoneal injection (i.p.) 60 minutes before sacrifice. Experiments were conducted
in the morning from 0900 to 1100 h to avoid the circadian fluctuation in neuroactive steroid
levels (Corpéchot et al., 1997). Blood was collected from the trunk immediately after
decapitation into red cap Vacutainer tubes for rats and into lithium-heparin microtainer tubes
(Becton Dickinson, Franklin Lakes, NJ, USA) for mice. It was centrifuged (3000 rpm for 15
min at 4°C) and serum samples were stored in plastic minivials at −80°C until use. A 6 µl
aliquot of serum was analyzed for blood ethanol levels using an SRI 8610c gas
chromatograph (SRI Instruments, Torrance, CA, USA) as described by Boyd et al., (2008).
Adequate measures were taken to minimize pain or discomfort of the animals. Animal care
and handling throughout the experimental procedures followed National Institutes of Health
Guidelines under University of North Carolina School of Medicine Institutional Animal
Care and Use Committee approved protocols.
Animals: cynomolgus monkeys
Eleven adult (4–5 year old) male cynomolgus monkeys (Macaca fascicularis) were
individually housed in 76 × 60 × 70 cm stainless steel cages in an environment maintained at
21 ± 1°C, with 30–50% humidity and a 11:13h light:dark cycle. The housing, feeding and
history of these monkeys are extensively described in Grant et al., (2008b). The study was
conducted in accordance with the Wake Forest University Animal Care and Use Committee
and the guidelines for the care and use of laboratory animal resources (Commission on Life
Sciences, National Research Council, 1996).
To administer the ethanol challenge to the monkeys and collect the necessary blood samples
following the challenge under non-stressful conditions, the monkeys were trained to sit in a
primate-restraining chair. The animals were then trained to accept an infant nasal-gastric
feeding tube for ethanol administration. The ethanol challenge was conducted as part of an
extensive series of assessments of the HPA axis previously described (Porcu et al., 2006a;
Porcu et al., 2006b). Ethanol (95%) (Warner-Graham, Cockeysville, MD, USA) was diluted
in tap water to a concentration of 30% (w/v) for the 1.5 g/kg dose. Blood draws (3 ml) were
obtained via the femoral vein with a 22g × 1 inch Vacutainer needle and a 3 ml Vacutainer
hematology tube (Becton Dickinson, Franklin Lakes, NJ, USA). All blood samples were
stored on ice until centrifuged (approximately 5 minutes). Samples were spun at 3000 rpm
for 15 minutes at 4°C. The plasma was pipetted into 2 ml microtubes and samples for
neuroactive steroid analysis were frozen at −80°C and stored until processing. Blood
samples were drawn before and 15, 60, 90 and 120 minutes following intragastric
administration of ethanol. Only the samples obtained before and 60 and 120 minutes
following ethanol administration were assayed for neuroactive steroids. Blood ethanol
concentrations (BEC) were determined in whole blood (20 µl) samples obtained from the
Vacutainer tube prior to centrifugation. Blood samples were sealed in air-tight vials
containing 500 µl of distilled water and 20 µl of isopropanol (10% internal standard) and
stored at −4°C until assay using gas chromatography (Hewlett Packard 5890 Series II,
Avondale, PA, USA).
Porcu et al. Page 4














Human blood samples were obtained from healthy men as previously described (Holdstock
et al., 2006). The study was conducted in compliance with the Declaration of Helsinki
(http://www.wma.net/e/policy/b3.htm) and was approved by the University of Chicago
Institutional Review Board. Briefly, nine healthy volunteers aged 21–35, participated in the
study. They were recruited from the university and surrounding community and screened by
telephone and in-person interviews. Screening included a physical examination and
psychiatric interview. Candidates were excluded from the study if they (i) had an Axis I
psychiatric disorder other than nicotine dependence or adjustment disorder in the last year,
(ii) had significant medical problems, (iii) had a body mass index (BMI) <19 or >26, or (iv)
had any history of drug-or ethanol-related problems (e.g., any legal, family or health
problems possibly related to drugs or ethanol) or a MAST score >5. Before participating,
participants read and signed a consent form which stated that the purpose of the study was to
investigate individual differences in the subjective responses to commonly used drugs.
Participants were informed that they might receive a tranquilizer, stimulant, ethanol or
placebo, and the possible side effects were listed. Participants were instructed to abstain
from drug use for 12 h before and after sessions, and compliance was verified at each
session with breathalyzer and urine drug screens for stimulants, barbiturates, opioids and
phencyclidine. Participants were instructed not to eat for 2 hours before the session. After
completing the study, participants were debriefed and paid for their participation.
Subjects participated in an orientation session followed by two experimental sessions (one
ethanol, one placebo), conducted 1 week apart. For the measurement of the GABAergic
neuroactive steroids, only samples from the ethanol session (before and after ethanol
consumption) were used. Sessions were conducted from 4:30 p.m. to 7:00 a.m. on the
following day. Subjects were tested individually at the University of Chicago Clinical
Research Center. After confirming negative breath and urine tests, an intravenous catheter
was inserted for blood draws, and participants consumed a light snack. Forty-five minutes
later, at 5:30 p.m., participants completed baseline mood questionnaires and a performance
task, vital signs were taken, and blood was drawn to determine baseline steroid levels.
Between 5:45 and 6:00 p.m., participants consumed two beverages (0.8 g/kg ethanol total),
each over a 5-min period, with a 5-min rest in between. Beverages consisted of water, sugar-
free grape Kool-aid sweetened with NutraSweet, and the appropriate concentration of
ethanol to make up a 16% ethanol solution by volume. The volume of beverage was 450 ml
for a 70-kg person, and adjustments were made for deviations in body weight by adjusting
the volume. Beverages were served cold in a Styrofoam cup with a lid and consumed
through a straw. Subjects were discharged at 7:05 a.m. During the sessions, when
participants were not completing dependent measures, they were free to watch television or
read. For GABAergic neuroactive steroids measures, only samples obtained at baseline, 60
and 120 minutes after the start of ethanol consumption were evaluated.
Neuroactive Steroid Analysis
Neuroactive steroids were measured in serum by GC-MS following purification by solid
phase extraction, as previously described (Porcu et al., 2009). Serum samples (300 µl) were
spiked with 400 pg/ml of each deuterated internal standard and applied to C18 solid phase
extraction columns (RPN1910, 500 mg, GE Healthcare, UK) that had been preconditioned
with 4 ml methanol and 4 ml distilled water. The column containing the sample was washed
with 4 ml distilled water in order to remove high polar impurities. Columns were dried
under vacuum for 30 minutes and neuroactive steroids were then eluted with 2 ml methanol.
The extracts were evaporated in a speed vacuum concentrator (Thermo Fisher Scientific,
Inc., Waltham, MA, USA). The dry residue was resuspended in 2 ml of ethyl acetate/
methanol (80/20, v/v) and the sample was filtered through a NH2 column (Supelclean LC-
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NH2, 500 mg, Supelco, Bellefonte, PA, USA) previously preconditioned with 4 ml of ethyl
acetate and 4 ml of ethyl acetate/methanol (80/20, v/v). The neuroactive steroids passed
unretained through the sorbent, and the eluate was collected. The NH2 column was further
rinsed with 2 ml of the solvent mixture and the combined eluates were evaporated in the
speed vacuum concentrator. Dried samples after purification were resuspended in 800 µl
methanol and transferred to derivatization vials (Wheaton, Millville, NJ, USA). Methanol
was evaporated and samples were derivatized in 450 µl of ethyl acetate and 50 µl of
heptafluorobutyric acid anhydride, followed by vortex mixing. Samples were allowed to
react for two hours at room temperature and were dried under a gentle stream of nitrogen.
Derivatized samples were resuspended in 10 µl of heptane and 2 µl of each sample was
injected in duplicate into the GC-MS. Analysis was carried out on an Agilent 6890 gas
chromatograph coupled to a 5973 mass selective detector (Agilent Technologies, Inc., Santa
Clara, CA, USA) operated in negative chemical ionization mode. A capillary column (30 m
× 0.25 mm, 0.25 µm film thickness, 5%-phenyl-methylpolysiloxane, J&W Scientific,
Agilent Technologies, Inc., Santa Clara, CA, USA) was used to separate the derivatives of
each neuroactive steroid. Samples were injected into the GC in splitless mode at 12 psi and
at 250°C using a 7683 series injector (Agilent Technologies, Inc., Santa Clara, CA, USA).
The carrier gas was ultrapure helium (99.9995%, Airgas National Welders, Durham, NC,
USA) set at constant flow of 1.0 ml/min. Methane (99.999% Airgas National Welders,
Durham, NC, USA) was the reagent gas. The initial GC oven temperature was 75°C (0.86
min hold), followed by an increase to 210°C at 35° increments (3 min hold), an increase to
235°C at 2.5° increments (9 min hold) and finally to 310°C at 25° increments (2 min hold).
The transfer line temperature was maintained at 280°C. Neuroactive steroids were analyzed
by single ion monitoring. The data acquisition was broken into retention windows
corresponding to the elution of the different neuroactive steroid groups. The temperatures of
mass spectrometer source and quadrupole were 150°C. Neuroactive steroids were quantified
by interpolation of linear regression standard curves. Calibration curves were made in 300 µl
distilled water spiked with 5 µl human charcoal-stripped serum (Gemini Bio-Products,
Woodland, CA, USA), with 400 pg/ml of each deuterated internal standard and with the
appropriate known concentration of neuroactive steroids (2, 10, 20, 50, 100, 200, 500, 1000,
2000 and 3000 pg/ml). A blank standard (5 µl human charcoal-stripped serum/300 µl
distilled water) was also included. Calibration curves underwent the same extraction
procedure as the samples.
Steroid standards (>99% purity) for 3α,5α-androsterone, 3α,5β-androsterone, 3α,5α-
androstandiol, 3α,5β-androstandiol, 3α,5β-THP, 3α,5β-THDOC and pregnenolone were
purchased from Steraloids, Inc. (Newport, RI, USA). Deuterium-labeled standards (>95%
purity) (d4–17,21,21,21)-3α,5α-THP and (d3–17,21,21)-3α,5α-THDOC were purchased
from Cambridge Isotope Laboratories, Inc. (Andover, MA, USA). (d4-2,2,4,4)-3α,5α-
androsterone was purchased from Cerilliant (Round Rock, TX, USA). 3α,5α-THP, 3α,5α-
THDOC and (d4–17,21,21,21)-pregnenolone (98% purity) were synthesized by Dr. R.H.
Purdy (Veterans Medical Research Foundation, San Diego, CA, USA). Derivatization
reagent heptafluorobutyric acid anhydride was purchased from Pierce (Rockford, IL, USA).
Organic solvents were pesticide grade from Thermo Fisher Scientific, Inc. (Waltham, MA,
USA).
Deoxycorticosterone was measured in mouse serum by radioimmunoassay as previously
described (Porcu et al., 2006a), with minor modifications (only 100 µl of serum was used for
deoxycorticosterone extraction). Progesterone levels were measured in mouse serum using a
commercially available radioimmunoassay (MP Biomedicals, Indianapolis, IN, USA).
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Statistical analysis was performed using a commercially available statistical program
(GraphPad Prism 4.0, GraphPad Software, San Diego, CA, USA). One-way ANOVA or
unpaired t-test was used to compare the effects of ethanol administration on serum
neuroactive steroid levels.
Results
Effects of acute ethanol administration on serum neuroactive steroids in rats
Basal levels of serum GABAergic neuroactive steroids in rats are presented in Table 1 and
are comparable to those previously reported using this GC-MS assay (Porcu et al., 2009).
Acute ethanol administration selectively increased serum levels of GABAergic neuroactive
steroids and their precursor pregnenolone (Figure 1). The doses of 1.5 and 2.0 g/kg ethanol
significantly elevated pregnenolone (+ 860 and + 1125%, respectively, p<0.001), 3α,5α-
THP (+ 228 and + 399%, respectively, p<0.001) and 3α,5α-THDOC (+ 134 and + 174%,
respectively, p<0.001). In contrast, the dose of 0.8 g/kg ethanol did not alter serum levels of
these steroids. 3α,5α-androsterone, 3α,5β-androsterone and 3α,5α-androstandiol were not
altered by ethanol administration at any dose examined. 3α,5β-THP was detected only in
4/10 control rats, 4/11 rats treated with ethanol 0.8 and 1.5 g/kg and 8/11 rats treated with
ethanol 2.0 g/kg. Its levels were not altered by any dose of ethanol administered. 3α,5β-
THDOC and 3α,5β-androstandiol were not detected in rat serum samples even following
ethanol administration. Blood ethanol levels in these rats were 81 ± 2.0, 212 ± 7.2 and 257 ±
6.0 mg/dl (average ± SEM) at 0.8, 1.5 and 2.0 g/kg, respectively.
Effects of acute ethanol administration on serum neuroactive steroids in C57BL/6J and
DBA/2J mice
Basal levels of serum GABAergic neuroactive steroids in C57BL/6J mice and DBA/2J mice
are reported in Table 1. Basal levels of 3α,5α-THP are significantly lower (−56%,
p<0.0005) in DBA/2J mice compared to C57BL/6J mice (Figure 2 and Table 1). A trend for
lower basal levels was also observed for pregnenolone (−43%, p=0.06), 3α,5α-androsterone
(−37%, p=0.09) and 3α,5α-THDOC (−33%, p=0.11).
Acute ethanol administration (2.0 g/kg, i.p.) significantly increased serum pregnenolone
levels in both C57BL/6J and DBA/2J mice (+241%, p<0.001 and +263%, p<0.005,
respectively; Figure 2). However, there was no increase in its neuroactive metabolites. In
fact, 3α,5α-THP serum levels were significantly decreased in C57BL/6J mice (−27%,
p<0.01) and were not altered in DBA/2J mice (Figure 2). 3α,5α-THDOC, 3α,5α-
androsterone, 3α,5α-androstandiol and 3α,5β-androstandiol were also not altered in either
strain of mice following ethanol administration (Figure 2). 3α,5β-THP, 3α,5β-THDOC and
3α,5β-androsterone were not detected in either C57BL/6J or DBA/2J mice following saline
or ethanol administration.
Given that acute ethanol increases pregnenolone levels in these mice but has differential
effects on its neuroactive metabolites, we decided to measure plasma levels of progesterone
and deoxycorticosterone, the immediate precursors of the GABAergic neuroactive steroids
3α,5α-THP and 3α,5α-THDOC, respectively. Basal progesterone and deoxycorticosterone
levels in C57BL/6J and DBA/2J mice are reported in Table 2. DBA/2J mice had
significantly lower basal deoxycorticosterone levels compared to C57BL/6J mice (−54%,
p<0.005). Acute ethanol administration significantly increased progesterone and
deoxycorticosterone serum levels in both C57BL/6J and DBA/2J mice. Progesterone levels
were increased by 515% (p<0.005) in C57BL/6J and by 803% (p<0.005) in DBA/2J mice.
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Deoxycorticosterone levels were increased by 185% (p<0.05) in C57BL/6J mice and by
308% (p<0.0001) in DBA/2J mice (Table 2).
Blood ethanol levels were 196 ± 4.1 and 196 ± 5.0 mg/dl (average ± SEM) for C57BL/6J
and DBA/2J mice, respectively.
Effects of acute ethanol administration on serum neuroactive steroids in cynomolgus
monkeys
Basal levels of serum GABAergic neuroactive steroids in cynomolgus monkeys are reported
in Table 1. Acute ethanol administration (1.5 g/kg, intragastrically) did not alter serum
levels of any of the neuroactive steroids measured (Figure 3). Average ± SEM blood ethanol
levels were 125 ± 24 mg/dl at 60 minutes and 139 ± 19 mg/dl at 120 minutes.
Effects of acute ethanol consumption on serum neuroactive steroids in healthy men
Basal levels of serum GABAergic neuroactive steroids in healthy men are reported in Table
1 and Table 3. Consumption of ethanol did not alter serum levels of any of the neuroactive
steroids measured (Table 3). Blood ethanol levels were 75 ± 10 mg/dl (average ± SEM).
Discussion
With the GC-MS procedure described here and elsewhere (Porcu et al., 2009), we have
extended previous investigations on the effects of ethanol on circulating neuroactive steroid
concentrations to eight different GABAergic neuroactive steroids in four different species.
This comprehensive examination revealed pronounced species differences in the ethanol-
stimulated concentrations of neuroactive steroids. Ethanol produces elevations of
pregnenolone and the 3α,5α-reduced metabolites of progesterone and deoxycorticosterone in
rats at doses of 1.5 g/kg or greater. In contrast, C57BL/6J mice exhibit a 27% decrease in the
progesterone metabolite 3α,5α-THP, while DBA/2J mice show no significant effect of
ethanol (2 g/kg), although both mouse strains exhibit increases in pregnenolone (241 and
263%), progesterone (515 and 803%) and deoxycorticosterone (185 and 308%) precursors.
Cynomolgus monkeys show no ethanol-induced (1.5 g/kg) changes in any steroids
measured. Similarly, ethanol (0.8 g/kg) had no effect on any steroid measured in humans.
Numerous previous reports have shown that acute ethanol administration increases 3α,5α-
THP and 3α,5α-THDOC levels in rat plasma and cerebral cortex (Barbaccia et al., 1999;
Morrow et al., 1999; Morrow et al., 1998; Porcu et al., 2004; Serra et al., 2003; VanDoren et
al., 2000), using chromatographic separation followed by radioimmunoassay to detect and
quantify the steroids. The present study replicates and extends these findings using a highly
sensitive and specific GC-MS assay (Porcu et al., 2009). Absolute values for basal 3α,5α-
THP and 3α,5α-THDOC levels are much lower using the GC-MS assay (Marx et al., 2009;
Marx et al., 2006b; Marx et al., 2006c; O'Dell et al., 2004; Porcu et al., 2009; Romeo et al.,
1998; Strohle et al., 2000) compared to previous radioimmunoassay studies mentioned
above, possibly indicating less specificity in the radioimmunoassay due to antibody cross-
reactivity. However the percent change in steroid levels following ethanol administration is
comparable to the previously published observations (vide supra).
Our results in rats replicate previous work on the effects of ethanol on 3α,5α-THP, 3α,5α-
THDOC and pregnenolone levels (Barbaccia et al., 1999; Korneyev et al., 1993; Morrow et
al., 1999; Morrow et al., 1998; O'Dell et al., 2004; Porcu et al., 2004; Serra et al., 2003;
VanDoren et al., 2000) and extend the analysis to the other GABAergic neuroactive steroids.
The results suggest that the effects of ethanol require doses of ethanol (1.5 – 2.0 g/kg)
capable of inducing blood alcohol levels greater than 200 mg/dl. Ethanol has a selective
effect on the progesterone and deoxycorticosterone metabolites and does not alter the DHEA
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and testosterone metabolites. Indeed, past studies on the effects of ethanol on these
precursors are controversial. It has been reported that acute ethanol administration either
decreases (Rivier, 1999) or increases testosterone levels in rats (Alomary et al., 2003);
furthermore, it does not alter (Morrow et al., 2001) or it decreases (Robel and Baulieu, 1995)
DHEA levels in several brain regions of rats.
In contrast, the same dose, route of administration and the time course of ethanol that
increase the GABAergic neuroactive steroids in rats, decrease 3α,5α-THP levels in C57BL/
6J mice and have no effect in DBA/2J mice. The differential effect of ethanol on serum 3α,
5α-THP levels may relate to the differential behavioral sensitivity to ethanol in these mouse
strains (Phillips and Crabbe, 1991). A differential effect of ethanol on brain 3α,5α-THP
levels has also been observed in these mouse strains, where acute ethanol administration
increased brain 3α,5α-THP levels in male DBA/2J mice (Gabriel et al., 2004), but not male
C57BL/6J mice (Finn et al., 2004c). Our results may differ due to the use of serum vs. whole
brain tissue. Indeed, the lack of effect of ethanol on serum levels of 3α,5α-THP coupled with
the ethanol-induced increase in brain levels of 3α,5α-THP in DBA/2J mice may suggest that
serum and brain levels of this neuroactive steroid could be differentially regulated.
Ethanol administration increases serum levels of pregnenolone and its metabolites
progesterone and deoxycorticosterone in C57BL/6J and DBA/2J mice. However, this effect
is not associated with an increase in the serum GABAergic neuroactive metabolites. These
two strains of mice have the same blood alcohol levels; values are similar to those in rats
that are capable of increasing 3α,5α-THP and 3α,5α-THDOC levels. Therefore, it is possible
that these strains of mice are less sensitive than rats to the ethanol-induced increases in
GABAergic neuroactive steroids, perhaps because of differences in the enzymatic activity
that leads to the conversion of progesterone and deoxycorticosterone into 3α,5α-THP and
3α,5α-THDOC, respectively. Previous studies have shown that C57BL/6J and DBA/2J mice
differ in the Srd5a-1 gene sequence that codes for the 5α-reductase type 1 enzyme,
suggesting that C57BL/6J and DBA/2J mice may express functionally distinct 5α-reductase
enzymes (Jenkins et al., 1991). Indeed, Finn et al., (2004a), showed that basal enzyme
activity was greater in the hippocampus and cerebral cortex of C57BL/6J vs. DBA/2J mice.
This difference in basal enzyme activity may explain the differences in basal levels of 3α,
5α-THP that we observed in these strains. However, the effects of ethanol on enzyme
expression or activity in the mouse have never been reported to the best of our knowledge.
Our data may suggest that adrenal 5α-reductase and 3α-hydroxysteroid dehydrogenase
activities in C57BL/6J and DBA/2J mice are impaired by ethanol, given that the increase in
plasma precursor steroids does not result in increased levels of the plasma 3α,5α-THP or 3α,
5α-THDOC.
We have also found that C57BL/6J and DBA/2J mice differ in basal 3α,5α-THP serum
levels and show a trend for different basal levels of the other GABAergic neuroactive
steroids. DBA/2J mice have lower basal 3α,5α-THP levels in serum compared to C57BL/6J
mice. A similar finding has been reported by Finn et al., (2003) with respect to 3α,5α-THP
levels in brain (but see also Finn et al., 1997). DBA/2J mice also show increased seizure
susceptibility and increased ethanol withdrawal-induced severity compared to C57BL/6J
mice (Finn et al., 2004a), suggesting that higher baseline neuroactive steroids (as found in
C57BL/6J mice) may exert a protective role against ethanol withdrawal.
In contrast to the rodent data, acute ethanol administration did not alter the GABAergic
neuroactive steroids in monkeys or humans. Ethanol was delivered to the stomachs of
cynomolgus monkeys and consumed in a beverage by the human subjects. Indeed, the same
dose of ethanol used in the human studies (0.8 g/kg), failed to alter neuroactive steroids in
rats, suggesting that a minimum blood alcohol level is required to increase neuroactive
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steroid concentrations. Higher doses could not be tested in humans due to ethical constraints.
In contrast, the dose of ethanol used in the monkey study (1.5 g/kg) significantly increased
neuroactive steroids in rats, but had no effect in cynomolgus monkeys. However, the same
dose of ethanol (1.5 g/kg) produced different blood alcohol levels in monkeys and rats (125
mg/dl vs. 212 mg/dl, respectively). Thus, it is possible that doses of ethanol which induce
higher blood alcohol levels may also increase circulating neuroactive steroids in monkeys.
Furthermore, given the possibility of local synthesis of neuroactive steroids in the brain
(Follesa et al., 2006; Sanna et al., 2004), we cannot rule out the possibility that lower doses
of ethanol increase brain levels of neuroactive steroids in all species.
In drug discrimination studies with monkeys as subjects, 1.0 g/kg ethanol is a robust
stimulus with substitution of GABAergic neuroactive steroids 3α,5α-THP, 3α,5β-THP and
3α,5α-androsterone, suggesting that the effects perceived by the animals are similar (Grant
et al., 1996; Grant et al., 1997; Grant et al., 2008a; Green et al., 1999). In addition,
circulating levels of progesterone, a direct precursor of 3α,5α-THP, influence the sensitivity
of ethanol substitution, shifting the dose-response curve to the left and suggesting additive
effects of circulating neuroactive steroids with administered ethanol (Grant et al., 1997).
Hence, it is possible that ethanol (1.0 g/kg) increases brain neuroactive steroids in monkeys
with no increase in plasma levels of these steroids. Further studies to measure neuroactive
steroids in brain tissue are needed to address this possibility.
The lack of change in serum levels of all these GABAergic neuroactive steroids and their
precursor pregnenolone in humans is consistent with previous studies. In fact, laboratory
administration of low or moderate doses of ethanol in a non alcohol-abusing population,
similar to the one reported here, had no effect on serum 3α,5α-THP levels (Holdstock et al.,
2006) or decreased 3α,5α-THP levels (Nyberg et al., 2005; Pierucci-Lagha et al., 2006).
However, others have reported that male and female adolescents seen in the emergency
room for alcohol intoxication had elevated serum levels of 3α,5α-THP, presumably because
of the elevated doses of ethanol ingested (although blood alcohol levels between 85–108
mg/dl were reported) (Torres and Ortega, 2003; Torres and Ortega, 2004). Interestingly,
administration of the neuroactive steroid inhibitor finasteride attenuates the subjective
effects of ethanol in individuals homozygous for the A allele at the GABAA receptor α2
subunit (GABRA2) gene polymorphism but not in individuals with the G allele (associated
with alcohol dependence), suggesting a role for neuroactive steroids in mediating ethanol
sensitivity in humans (Pierucci-Lagha et al., 2005). Therefore, it is possible that our results
may not be generalized to the entire population and the genotype of the individuals in the
present study was not determined. Thus, the effects of ethanol on circulating levels of
GABAergic neuroactive steroids appear to be influenced by dose, metabolism and genotype
as well as different analytic methods to measure neuroactive steroids or environmental
factors that influence neuroactive steroid synthesis in humans. Alternatively, the effects of
ethanol on neuroactive steroid levels may involve neurosteroidogenesis independent of
circulating steroid levels. Nonetheless, we cannot rule out the possibility that higher
intoxicating doses of ethanol may increase circulating neuroactive steroids in healthy human
subjects. The potential ethanol-induced increases in GABAergic neuroactive steroids may
relate to ethanol sensitivity and may play a role in preventing excessive alcohol consumption
in healthy individuals (Morrow et al., 2006). In contrast, alcohol-dependent subjects show
decreased neuroactive steroid responses in agreement with suppressed HPA axis function
(Hill et al., 2005, Porcu et al., 2008, Romeo et al., 1996). The loss of neuroactive steroid
responses may promote excessive alcohol consumption to achieve the desired effects of
ethanol. Excessive alcohol consumption is a significant risk factor for alcohol dependence
and alcoholism. Thus, neuroactive steroids may have therapeutic utility in restoring ethanol
sensitivity in alcohol-dependent subjects.
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In conclusion, these results show clear species differences between rats and mice at
comparable ethanol doses and blood alcohol concentrations. Species differences between
rats and monkeys are confounded by the different blood alcohol levels achieved using the
same dose of ethanol. Differences between humans and these other species cannot be
assessed due to ethanol dosing constraints. In fact, the same dose used in the human study
failed to alter circulating neuroactive steroids in rats. Rats are unique in their pronounced
elevation of GABAergic neuroactive steroids, while this effect was not observed in mice and
cynomolgus monkeys at comparable ethanol doses, although comparable blood alcohol
levels were not achieved. Translational studies on the role of neuroactive steroids in ethanol
actions, including tolerance and risk for ethanol abuse or dependence should consider the
similarities and differences in neuroactive steroids across species.
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Effect of ethanol administration to male rats on serum levels of GABAergic neuroactive
steroids. Ethanol (0.8, 1.5 and 2 g/kg, 20% v/v in saline) or saline were administered i.p. 60
minutes before sacrifice. Levels are expressed as pg/ml and are average ± SEM of ten rats in
the saline-treated group and eleven rats in the ethanol-treated groups. 3α,5β-THP was
detected only in 4/10 rats in the saline-treated group and 4/11, 4/11 and 8/11 rats in the
ethanol-treated groups at 0.8, 1.5 and 2.0 g/kg, respectively. 3α,5β-THDOC and 3α,5β-
androstandiol were undetectable (n.d.). *p<0.001 vs the respective saline-treated control
values; one-way ANOVA followed by Newman-Keuls post hoc test.
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Effect of ethanol administration to male C57BL/6J and DBA/2J mice on serum levels of
GABAergic neuroactive steroids. Ethanol (2 g/kg, 20% v/v in saline) or saline were
administered i.p. 60 minutes before sacrifice. Levels are expressed as pg/ml and are average
± SEM of 4–14 mice per group (exact number is indicated in each bar). 3α,5β-THP, 3α,5β-
THDOC and 3α,5β-androstandiol were undetectable. *p<0.01, **p<0.005 and ***p<0.001
vs the respective saline-treated group in each strain; unpaired t-test comparing the saline-
and ethanol-treated groups for each strain. #p<0.0005 vs the saline-treated C57BL/6J group;
unpaired t-test comparing only the saline-treated groups.
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Effect of ethanol administration to male cynomolgus monkeys on serum levels of
GABAergic neuroactive steroids. Ethanol (1.5 g/kg, 30% w/v in tap water) was administered
intragastrically and blood samples were collected before, 60 and 120 minutes from ethanol
administration. Levels are expressed as pg/ml and are average ± SEM of twelve subjects. 3α,
5β-androstandiol was detected only in 9/12 subjects before ethanol administration and in
10/12 subjetcs after ethanol administration. 3α,5β-THDOC, 3α,5β-androsterone and 3α,5β-
androstandiol were undetectable (n.d.).
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Table 2
Effects of acute ethanol administration on serum levels of the neuroactive steroid precursors progesterone and
deoxycorticosterone in male C57BL/6J and DBA/2J mice.
Progesterone Deoxycorticosterone
C57BL/6J
Saline 2.3 ± 0.6 7.7 ± 1.1
Ethanol 14.4 ± 3.6b 21.8 ± 5.3a
DBA/2J
Saline 1.3 ± 0.1 3.5 ± 0.6d
Ethanol 11.4 ± 2.2b 14.3 ± 1.7c
Ethanol (2 g/kg, 20% v/v in saline) or saline were administered i.p. 60 minutes before sacrifice. Levels are expressed as ng/ml and are average ±






p<0.0001 vs the respective saline-treated group; unpaired t-test.
d
p<0.005 vs the respective saline-treated C57BL/6J mice group; unpaired t-test.
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Table 3
Effects of ethanol consumption on serum levels of GABAergic neuroactive steroids in healthy men.
−15 min 60 min 120 min
Pregnenolone 296.9 ± 28.9 262.4 ± 10.5 239.1 ± 14.9
3α,5α-THP 124.8 ± 12.2 144.6 ± 12.6 134.4 ± 10.2
3α,5β-THP 109.2 ± 4.5 105.1 ± 1.7 105.2 ± 2.1
3α,5α-THDOC 63.0 ± 21.6 65.3 ± 19.6 45.1 ± 7.5
3α,5β-THDOC n.d. n.d. n.d.
3α,5α-Androsterone 97.3 ± 12.0 63.4 ± 6.4 101.1 ± 22.9
3α,5β-Androsterone 177.5 ± 88.7 275.8 ± 105.6 245.2 ± 71.9
3α,5α-Androstandiol 34.9 ± 4.3 31.8 ± 2.4 34.6 ± 3.0
3α,5β-Androstandiol 23.4 ± 1.4 27.3 ± 2.6 22.4 ± 1.2
Ethanol (0.8 g/kg, 16% w/v beverage solution) was consumed at time 0 and blood samples were collected 15 minutes before and 60 and 120
minutes from the start of ethanol consumption. Levels are expressed as pg/ml and are average ± SEM of eight subjects. 3α,5β-androsterone was
detected only in 6/8 subjects 60 minutes after ethanol consumption; 3α,5β-androstandiol was detected only in 7/8 subjects 120 minutes after
ethanol consumption. 3α,5β-THDOC was undetectable (n.d.).
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